by David Rubin | Mar 2, 2021 | In the Press
Click here to watch Dr. Rubin and Dr. Long review the role of cell trafficking in IBD pathogenesis and how therapies that modulate immune cell trafficking compare with other agents that target the inflammatory response in IBD.
by David Rubin | Feb 12, 2021 | In the Press
by David Rubin | Dec 16, 2020 | In the Press
Many people with Ulcerative Colitis wonder whether it’s possible to have a satisfying sex life. Dr. David Rubin discusses how to address the situation with your physician and partner. Read more here.
by David Rubin | Dec 5, 2020 | Coronavirus, Rubin's Reflections
SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...
by David Rubin | Oct 29, 2020 | In the Press
Dr. Rubin was recently announced as one of three recipients of the 2020 Sherman Prize. Sherman Prize recipients “are outstanding individuals who consider the whole patient experience — not just the serious symptoms, but also the psychological and practical...